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SUMMARY 
A reasonably realistic physical model has been described for the simultaneous longitu- 
dinal spreading, fluid flow and absorption of drugs in solution under non-steady-state 
conditions in the small intestinal tract. Various input cases included first-order and zero- 
order stomach emptying and input from an infinite drug reservoir at constant infusion 
rate. The mathematical solutions were unique and rigorous. Theoretical simulations using 
reasonable physical parameter values illustrated the interrelationships of the longitudinal 
spreading diffusion coefficient, flow rate, apparent permeability coefficient and intestinal 
length on the change in concentration-distance profiles with time and the kinetics of 
appearance of unabsorbed drug at the end of the intestinal segment. The model is 
accessible to the design of intestinal absorption experiments and data interpretation on a 
quantitative mechanistic basis and also provides the way for studying intestinal absorp- 
tion under more realistic situations. 
INTRODUCTION 
In advancing systematic studies of simultaneous bulk fluid flow and absorption in the 
intestinal tract and the concept of the anatomical reserve length for absorption, a, physical 
model embodying reasonably realistic phenomenological events under non-steady-state 
conditions is needed. 
Furthermore, there is a gap in our understanding of the flow pattern of drugs in solu- 
tion ~,nd dispersed systems and the factors affecting the flow patterns on a quantitative and 
mechanistic basis. The flow pattern is believed to have a significant influence on absorp- 
tion as the drug courses its way in a liquid flowing along the intestinal tract. When a non- 
* To whom correspondence should be addressed. 
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absorbable marker in solution is introduced into the intestinal lumen either from an 
infinite reservoir or as a bolus, longitudinal zonal spreading will very likely occur. This 
spreading will be due to non-plug flow regimes, turbulence, surface irregularities, peristal- 
tic and villous activities, S-shaped course of the intestines, binding to mucoidal substances 
on the membrane surface and possibly, the presence of the aqueous boundary layer. In 
situ rat intestinal segments and in vitro silicone rubber tubes appropriately designed as 
model intestines can be used. The longitudinal spreading of the non-absorbable solute 
determined by following the outflow concentration of an intestinal segment of a given 
length with time will mirror the hydrodynamic events in the lumen and, in turn, the 
spreading characteristics of absorbable solutes, when compared with that of the non- 
absorbable marker solute, will then mirror the absorption event. 
This paper emphasizes the description of a comprehensive physical model, rigorous 
solution of the mathematics and ensuing theoretical predictions which provide the basic 
framework whereupon experiments can be designed, carried out and quantified on a 
mechanistic basis. 
THEORY 
General description of the model 
The physical model for the sinmltaneous turbulent diffusion, fluid flow and absorp- 
tion of a drug in solution in the intestinal tract taken as a hollow cylinder is depicted in 
Fig. 1. Mass balance within a cylindrical element at non-steady-state is described by 
AC ( AC)i ( AC)[ -2nrAxPeC a'r 2 A x . ~ - ~ -  QC-nr2De -Ax x -  QC-¢rr2De . ~ x  x+Ax (1) 
where C = C(x, t), the drug concentration at any distance, x, along the intestine and time, 
t; De = effective diffusion coefficient for longitudinal spreading, cm2/sec; Q = bulk fluid 
flow rate, cma/sec; Pe = apparent permeability coefficient, cm/sec, for the absorption 
process (He et al., 1979); and r = radius of the intestinal lumen, cm. In the limit of Ax 
approaching zero, 
aC i~2C OC 
aT (2) 
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Fig. i. Physical model for the simultaneous turbulent diffusion, fluid flow and drug absorption in the 
small intestines at non-steady-state. 
where 
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ot = De (3a) 
= Q#rr 2 (cm/sec) (3b) 
3, = 2Pelt (sec -1) (3c) 
The parameter # is then the linear flow velocity. In the event where a non-absorbable 
marker is used, the partial differential equation becomes 
0C 02C 0C 
- -  =o l  - ~  - - -  ( 4 )  
Ot ~xx z 8x 
In Eqns. 2 and 4, the diffusion coefficient for longitudinal zonal spreading for the 
absorbable solute is assumed to be the same as that for the non-absorbable solute. 
The form of the solution sought is 
C(x, t) = C*(x, t ) .  e ~x/2e-~2t/4a-~tt (5) 
whereupon the use of this expression transforms Eqn. 2 to a simpler one: 
aC'(x, t) a2C'(x, t) (6) 
~ , .  
at ax 2 
The initial boundary condition is 
C(x,0)= 0 (7a) 
and, correspondingly, 
C*(x,0) = 0 (7b) 
Since C(x, t) is bounded as x approaches infinity, i.e. 
C(oo, t) = 0 (8a) 
it follows that 
C'(oo, t)= 0 (8b) 
There are several drug-input conditions at x = 0 which are of general interest. 
(a) Infinite drug reservoir at constant infusion rate: 
C(0, t) = Co (9a) 
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or 
C*(0, t) = Co e (f/4a+v)t (9b) 
(b) Zero-order infusion rate of finite mass of drug: 
C(0, t) = Co - kot 
or 
C*(0, t) = (Co - kot) e (02/4a+v)t 
(c) First-order infusion rate of finite mass of drug: 
C(0, t) = Co e -kI t  
or 
C*(0, t)  = Co e(32/4a+~-kOt (11 b) 
(d) Pulse input: 
C(0, t) = Co e -kt  (k = oo) (12) 
where Co = drug concentration at the entrance of the intestinal lumen; and ko, kl and 
k = drug input rate constant for the zero-order, first-order and pulse situations, respec- 
tively. 
Approach to the mathematical solution 
(lOa) 
(lOb) 
( l l a )  
U*(x, s) = AI e x x / ~  + A2 e - x x / ~  (14) 
where U* = U*(x, s) = Laplace transform of C*(x, t); and s = a variable in time, t. 
The solution is 
* . d2U * 
sU - C (x, O) = ads 2 (I 3) 
Various approaches to the solution of Eqn. 6 and accompanying boundary conditions 
are available. The Laplace transformation method is the easiest since many of the inverses 
of the transform pertinent here are already tabulated (Carslaw and Jaeger, 1959a). An 
alternative method leading to the same analytical solution is the classical approach 
:'.mploying Duhamers theorem (Carslaw and Jaeger, 1959b; Churchill, 1958). 
Taking the Laplace transform of Eqn. 6, one gets 
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Since U*(x, s) is bounded as x-~ 0% it follows that the integration constant AI must be 
zero. Therefore, 
U*(x, s)= A2 e -Xvq?~ 
where A2 is to be determined next from the various drug input conditions. 
Case A: In.finite drug reservoir at constant infusion rate. 
From Eons. 9b and 15, 
(15) 




U*(x,  s) = Co e -x'd~ 
s - ~  (18)  
whereupon the inverse is 
C*(x,t) C°e~t { I~- -~  x/;,~J I ~ - ~  ~/~ ~" ]2 e -x ~x/~-fferfc x 1 = + eX ~,¢~7-derf c x I - + (19) 
Consequently, with Eqn. 5, the fraction of drug remaining at any distance, x, and time, 
t, is 
C(x' t)-eeX/2"{ e - c o  -  xx/~erfe~. ____L2x/t~tx - /~.] + eX ~,/~ erfcI~__~ + x/~l ) x  (20) 
It can be readily shown that Eqn. 20 satisfies all boundary conditions. 
From Eqn. 20, the steady-state concentration ratio of absorbable drug at the end of an 
intestinal segment of length, ~, and incoming concentration arrives expectedly at an 
asymptotic value as expressed by 
C(~, **)_ exp (1 - ~/1 + 400,/82) < 1.0 
Co 
(21) 
In the case of a non-absorbable solute (7 - 0) at steady-state, C(~, o0) = Co. The binomial 
expansion of the square-root term, neglect of insignificant high order expansion terms 
and algebraic arrangement will reduce Eqn. 21 to 
C(£, °°)_ exp (2~rQPe)  
Co - (400'/82 < 1.0) (22) 
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This final expression has been used in studies involving the simultaneous bulk fluid flow 
and intestinal absorption of n-alkanoic acids and steroids (Ho et al., 1979; Komiya et 
al., 1980) and also in developing the concept of the anatomical reserve length for absorp- 
tion. 
Case B: Zero-order infusion of finite amount of drug 
With the input boundary condition expressed in Eqn. 10b, the constant of integration 
A2 in Eqn. 15 is 
Co ko (23) 
u * ( o ,  s) = A2  - (s - t~) (s - ~)2 
and, therefore, 
U*(x, s)= IsC--°~ (s k_-°-~)~] e - ' ' /~  (24) 
After taking the inverse of the Laplace transform to obtain C*(x, t) and substituting into 
Eqn. 5, one arrives at 
C(x, t)Co - e~X/2~/e-X ~ x / ~ - e r f c V 2  [ c~ L2~/t~tx"- _ ~ 1  + eX ~,d~" ~ erfcI.~_~ + Vt~ } x  
2Co t - ~ - ~ ) e  -x ~',/~erfc x _ 
+ (t + ~ - ~ )  eXX/~'~ erfcI~-~ + ~/~1/ (25) 
Case C: First-order infusion of finite amount o[ drug 
As can be seen, the first-order input condition in Eqn. 1 lb has the identical form as 
that for the infinite drug reservoir case in Eqn. 9b. Consequently, one can readily write 
the following expressions: 
U*(x, s) = Co e - x ~ - ~  (26) 
s - ( ~  - k l )  
and finally, 
C'(x, t) = 2 e - x ~  erfc x _ 
+ eX~/(¢- kO/¢~ erfc ~ + N/(~ _ kl) tl / ( 2 7 )  
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c'x t' '"'/ l - e -xx/(/i-kl)/c~ erfc - ~(~ -- kl) t 
Co 2 
" ,l/ + e xx/(i~- kl)/a erfc + X/(~ - kl) (28) 
There are no constraints on the value of the first-order input constant k~ placed on Eqn. 
28. However, the ease of k~ >/ j  is not particularly relatistic, since in physiological situa- 
tions the disappearance rate of the drug in solution from the stomach is less than the 
combined effects of flow and spreading within the intestines. Consequently, kl ~</j is the 
usual situation. 
In examining Eqn. 28 for the first-order input case and Eqn. 25 for the zero-order 
input case retrospectively, one observes that these equatio,s are somewhat similar to Eqn. 
2() for the infinite reservoir case, the important distinction being modifications that bring 
about the limiting situation at infinite time of 
C(x, **) 
- 0  (29) 
Co 
which is due to the finite amount of drug introduced into the intestinal lumen at first- 
order or zero-order rates. 
THEORETICAL RESULTS AND DISCUSSION 
Computations were carried out using the following reasonable values of physical 
parameters: 
Effective diffusion coefficient 
Flow rate 
Intestinal length 
Effective radius of rat intestines 
Effective permeability coefficient 
First-order infusion constant 
De = 10 -s and 10 -2 cm2/sec 
Q = 0.5 and 2.0 ml/min 
£ = 2 5 a n d 5 0 c m  
r = 0.18 cm 
Pe = 0, 3 X 10 -s and 3 X 10 -4 cm/sec 
kl = 10 -1, 10 ..2 and 10 -3 sec -1 
To demonstrate the predictions of the model the infinite drug reservoir and first-order 
infusion cases were employed. 
Infinite drug reservoir at constant infusion rate 
In Fig. 2 the large longitudinal zonal spreading of a non-absorbable solute has a 
marked influence on the character of the outflow to inflow concentration ratio vs time 
profile. The effective diffusion coefficient of 10 -s cm2/sec corresponding to ordinary 
molecular diffusion has negligible effect on spreading, while the magnitude of De being 
10 -2 cm2/sec is a reflection of strong eddy diffusion currents. At steady-state, the con- 
centration ratios converge to unity. 
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Fig. 2. Changes in outflow-to-inflow concentration ratio with time for a non-~bsorbable marker solute 
for effective spreading diffusion coefficients of 10 -s and 10 -2 cm 2/sec. Th~ tlow rate is 0.5 ml/min. 
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Fig. 3 illustrates the changes in outflow to inflow concentration ratio with time for 
absorbable solutes with different permeability coefficients under the influence of longi- 
tudinal spreading. The profile of a non-absorbable marker solute (Pe = O) is also shown. 
The sigmoidal-shaped curves in the non-steady-state region are separated from each other 
both vertically and horizontally. The concentration ratios at steady-state are 0.9 and 0.36 
for Pe of 3 X l0  -s and 3 × l0  -4 cm/sec, respectively. 
In contrast to Fig. 3 where the flow rate is 0.5 ml/min, tl~e ce.:~c~:~'~tration ra t io- t ime 
plots at the flow rate of 2 ml/min in Fig. 4 are shifted dowl~ the ~ime scale due to the 
shorter residence time. The residence time is the time it takes for a fl~Jwing liquid to dis- 
place a given volume of liquid within a tube and can be roughly esti~nated by dividing the 
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Fig. 3. Changes in outflow-to-inflow concentration ratio with time for absorbable solutes with effec- 
tive permeability coefficients of 3 × 10 -s and 3 X 10 -4 cm/sec under the influence of a zonal 
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Fig. 4. Changes in outflow-to-inflow concentration ratio with time for absorbable solutes with effec- 
tive permeability coefficients of 3 X 10 -s  and 3 × 10 ..4 cm/sec under the influence of a zonal spread- 
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Fig. 5. Concentration ratio-distance prof'fles as a function of time for an absorbable solute for two 
longitudinal spreading situations. 
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lumenal volume of the tube by the flow rate. As can be seen, there are smaller differences 
in shifts in the horizontal and vertical directions in the non-steady-state region of the 
profiles. Because of the shorter residence time, the steady-state concentration ratio,J at 
2 ml/min are 0.98 and 0.78 for Pe equal to 3 X 10 -s and 3 × 10 -4 era/see, respectively, 
as compared to 0.90 and 0.36 at 0.5 ml/min. 
Lastly, Fig. 5 shows typical examples of zonal spreading profiles for absorbable solutes 
within the length of the tube at various time intervals. The spreading is expectedly less 
when eddy diffusion currents are small. 
In Figs. 2 - 4 ,  the fraction of solute remaining in the intestinal segment of length ~ at 
steady-state is C(~, oo)/Co. It follows that the steady-state fraction absorbed is 
F.A. = 1 . . . .  C(~, oo) 
co (30) 
and, with Eqn. 22, 
2~rrl/Pe ~ 
F.A. = l - e x p  ~ ] (31) 
First-order infusion of.finite amount o f  drug 
Fig. 6 shows the C(~, O/Co 0.e. ratio of outflow concentration at intestinal length ~ at 
time t to the initial concentration at the entrance of the intestines) vs time profiles as a 
function of permeability coefficients representing a non-absorbable solute (P¢ = 0), 
membrane-controlled solute (Pc = 3 X l0 -s cm/sec) and aqueous boundary layer-con- 
trolled solute (Pc - 3 X l0 -4 cm/sec). The conditions of flow rate, infusion rate, intestinal 
length and effective diffusion coefficient are constant. The area under the curve becomes 
progressively smaller as the permeability of the intestines increases. 
All other factors being constant, the influence of longitudinal spreading on absorption 
is seen by comparing the corresponding curves in Fig. 6. The upward part of the curve is 
almost perpendicular when the effective diffusion coefficient is in the order of molecular 
diffusivity (De = l0  -s cm2/sec) and has more curvature when the effective diffusion 
coefficient is 1000-fold larger. The appearance of unabsorbed drug at the end of the 25 
cm length occurs sooner when spreading is larger. However,the extent of drug 
unabsorbed, as indicated by the respective areas under the curves for similar permeability 
coefficients, is not significantly affected even by the large differences in longitudinal 
spreading diffusion coefficients used within the simulated conditions. Generally, large 
spreading coefficients tend not only to bring about the early appearance of unabsorbed 
drag at the end of the small intesthles beyond that expected for simple plug-flow, but 
also to decrease the extent of absorption by effectively decreasing the residence time of 
the." drug in the intestines beyond that determined by plug-flow alone. Examples of the 
effect of longitudinal spreading on concentration-distance curves with time are shown in 
Fig. 7. 
Before ptoe.ceding further with the results of other situations, i.e. the effect of flow 
rate, infusion rate and intestinal length on absorption, the interpretation of the areas 
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Fig. 6. Effect of  longitudinal spreading diffusion coefficient on the outflow to initial inflow concentra- 
tion ratio as a function of permeability coefficients for a 25 cm intestinal length. The flow rate is 0.5 
ml/min and infusion rate constant is 10 -2 sec -1 . 
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Fig. 7. Effect of  spreading diffusion coefficient on concentration-distance curves with time. The flow 
rate is 0.5 ml/min; infusion rate constant is 10 -2 sec -1 and maximum length is 25 cm. 
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under the curves, such as those found in Fig. 6, should be discussed with respect to the 
extent of absorption. In general, the total area under the C(£, O/Co vs t curve (AUC) is 
proportional to the total amount of drug unab~orbed ~. When there is no absorption as in 
the situation of an unabsorbable marker, 
AUC (Pc = O) ~ Total amount of unabsorbed marker -- Total dose infused into the 
intestines (32) 
The fraction of to~al drug absorbed within intestinal length £ relative to the total dose 
infused into the intestines via the stomach becomes: 
F.A. = AUC(Pe = O) - AUC(Pe > 0) 
AUC(Pe = 0) (33) 
where F.A. = fraction of total drug absorbed within intestinal length £ relative to the 
total dose infused into the small intestines and 
AUC(Pe > O) 
AUC(Pe = O) 
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Fig. 8. Influen¢~ of  flow rate on the outflow to initial inflow concentration ratio for various perme 
ability coefficients in a 25 cm intestinal length. The infusion rate constant  is 10 -2 sec - I  . 
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Fig. 9. Influence of  intestinal length on the outflow to initial inflow concentration ratio with t ime for 
various permeability coefficient cases. The effective diffusion coefficient is 10 -2 cm 2/sec, flow rate is 
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Fig. 10 Infusion rate effect on drug appearance at the end of  25 cm intestinal length for various 
permeability coefficients. The effective diffusion coefficient is 10 -2 cm 2/sec and flow rate is 0.5 ml/ 
min. 
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Fig. 8 illustrates the change in the concentration ratio of the appearance of solute to 
the initial reservoir with time as a function of flow rates. When the 2 ml/min rate is 
compared with the slower flow rate of 0.5 ml/min, the appearance of unabsorbed solute 
is faster by a factor of 4; however, the fraction of the dose absorbed is much less due to 
the smaller residence time in the 25 cm segment. 
The effect of intestinal length on the extent of absorption can be seen in Fig. 9. By 
increasing the length from 25 to 50 cm, the total fraction unabsorbed in decreased about 
two-fold for the highly permeable solute (lower curves) and less significantly for the less 
permeable solute (upper set of curves). 
Fig. 10 illustrates the effect of infusion rate constants. Bolus-like input into the 
intestines (k = 10 -1 sec -1) exhibits a smaller AUC as, for example, compared to that for 
k = 10 -3 sec -~. However, when the areas are compared to their respective AUC (Pe = 0), 
the fractions of drug absorbed are identical and, therefore, independent of the input rate 
constant. 
RELEVANCE OF THE PHYSICAL MODEL 
The partial differential equation and boundary conditions of the physical model are 
believed to be the most general, physically reasonable statements of what goes on within 
the small intestines representing comprehensively and concisely the mass balance relation- 
ships for solutes during flow and absorption. The mathematical solutions for various 
situations are rigorous and yield relationships useful in experimental design and data 
analysis in in vivo animal and human studies. 
Employing a steady-state, in situ, single-pass perfusion technique in the small intestines 
of the rat and steroid solutes varying in lipophilicity, Komiya et al. (1980) found quanti- 
tative relationships between the flow rate and the apparent permeability coefficients, 
specifically the permeability of the aqueous boundary layer. Here, Eqns. 22 and 31 were 
used in the data analysis. The quantitative effect of hydrodynamics on absorption was 
discussed in the light of the S-shaped course of the intestines, rough surfaces due to villus 
projections, peristalsis and villvs motility. To date, very little is known from the experi- 
mental standpoint as regards the influence of flow rate on the degree of longitudinal 
spreading in the intestines. This gap in knowledge should be breached before physically 
relevant parameters and their quantitative relationships can be applied to non-steady-state 
flow, spreading and absorption experiments to test the concepts of the model. 
The physical model is founded on the existence of a time-dependent concentration 
gradient as the drug in the fluid flows down the small intestines, i.e. the intestine is longi- 
tudinally not a well-mixed compartment I. This premise, which intuitively makes physical 
sense, is supported by a host of human intubation studies. Soergel (1971) followed the 
appearance of a single bolus dose of a non-absorbable marker (phenol red) downstream in 
the jejunum and ileum (70 and 140 cm from the infusion tip positioned at the ligament 
of Treitz) to measure the average flow rates in fasted and non.fasted humans. Sharply 
I Mathematical details of the amounts of drug leaving the intestines of length ~, amounts absorbed are 
forthooming in the manuscript entitled 'Relating gastrointestinal absorption and blood levels by the 
physical model approach'. 
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defined parabolic concentration-time curves, similar to those shown in Fig. 9, were 
observed from aspirated samples in the jejunum and ileum. In a classical study Borgstrom 
et al. (1957) employed a liquid test meal of homogenized oil, protein and glucose mixture 
and found that glucose, protein and fat were completely absorbed within 100 cm of the 
jejunum which indicates an anatomical reserve length of about 250 cm for an average 
small intestinal length of 350 cm. The reserve length is the length of small intestines yet 
available for absorption (Ho et al., 1979). 
In conclusion the proposed physical model provides a rigorously potential framework 
within which the bioavailability of orally administered drugs, the efficacy of pharmaceu- 
tical formulations and the effects of gastrointestinal physiological factors can be studied 
and mechanistically interpreted via in vivo perfusion techniques in the intubated human 
(Sladen, 1975). 
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